Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis (ACE)
Sponsor: Celltrion
Terminated
Not enough number of enrolling patient
Other terminated trials from Celltrion
Other Ulcerative Colitis trials with similar outcome
This PHASE4 trial investigates Ulcerative Colitis and is currently terminated or withdrawn. Celltrion leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Oct 2019 — Feb 2020 [monthly]
Terminated PHASE4
-
Sep 2019 — Oct 2019 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jan 2019 — Sep 2019 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Celltrion
- Kyungpook National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .